Carol Moreno
- Genetics top 0.1%
- Pathology and Forensic Medicine top 0.2%
- Immunology top 2%
- Molecular Biology top 10%
- Hematology top 1%
- Co-authors
- Emili MontserratRichard J. RomanJozef LazarPaolo GhiaHoward J. JacobMahesh MistryPeter HillmenAlessandra Tedeschi
- Topics
- Chronic Lymphocytic Leukemia Research (91 papers)Lymphoma Diagnosis and Treatment (59 papers)Immunodeficiency and Autoimmune Disorders (36 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Carol Moreno
153 papers receiving 5.4k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Genetics 3.3k
- Pathology and Forensic Medicine 2.6k
- Immunology 1.5k
- Molecular Biology 1.0k
- Hematology 934
Countries citing papers authored by Carol Moreno
This map shows the geographic impact of Carol Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Moreno more than expected).
Fields of papers citing papers by Carol Moreno
This network shows the impact of papers produced by Carol Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Moreno. The network helps show where Carol Moreno may publish in the future.
Co-authorship network of co-authors of Carol Moreno
This figure shows the co-authorship network connecting the top 25 collaborators of Carol Moreno. A scholar is included among the top collaborators of Carol Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Moreno. Carol Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 1 | |
| 3 | 10 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia breakdown → | 146 |
| 8 | Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohortbreakdown → | 124 |
| 9 | 23 | |
| 10 | 33 | |
| 11 | 2 | |
| 12 | 63 | |
| 13 | 1 | |
| 14 | Improvement in hematologic function, disease burden/symptoms with ibrutinib in older treatment-naive (TN) patients with chronic lymphocytic leukemia (CLL) in phase 3 RESONATE-2 (TM) | 1 |
| 15 | Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study | 10 |
| 16 | 56 | |
| 17 | Liver transplantation for acute liver failure in adults | 1 |
| 18 | 7 | |
| 19 | 50 | |
| 20 | 44 |
About Carol Moreno
Carol Moreno is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 155 papers that have together received 5.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (91 papers), Lymphoma Diagnosis and Treatment (59 papers) and Immunodeficiency and Autoimmune Disorders (36 papers). The work is most often cited by research in Genetics (3.3k citations), Pathology and Forensic Medicine (2.6k citations) and Hematology (934 citations). Carol Moreno has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Emili Montserrat, Richard J. Roman, Jozef Lazar, Paolo Ghia, Howard J. Jacob, Mahesh Mistry, Peter Hillmen, Alessandra Tedeschi, James P. Dean and Thomas J. Kipps. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.